Effect of "fast track" admission for acute myocardial infarction on delay to thrombolysis.

OBJECTIVE--To evaluate the impact of a fast track triage system for patients with acute myocardial infarction. DESIGN--Comparison of delays in admission to hospital and in receiving thrombolytic treatment before and after introducing fast track system with delays recorded in 1987-8. Patients fulfilling clinical and electrocardiographic criteria for myocardial infarction were selected for rapid access to the cardiac care team, bypassing evaluation by the medical registrar. SETTING--Major accident and emergency, cardiac and trauma centre. SUBJECTS--359 patients admitted to the cardiac care unit during 1 February to 31 July 1990 with suspected acute infarction. MAIN OUTCOME MEASURES--Accuracy of diagnosis and delay from arrival at hospital to thrombolytic treatment. RESULTS--248 of the 359 patients had myocardial infarction confirmed, of whom 127 received thrombolytic treatment. The fast track system correctly identified 79 out of 127 (62%) patients who subsequently required thrombolytic treatment. 95% (79/83) of patients treated with thrombolysis after fast track admission had the diagnosis confirmed by electrocardiography and enzyme analysis. The median delay from hospital admission to thrombolytic treatment fell from 93 minutes in 1987-8 to 49 minutes in fast track patients (p less than 0.001). Delay in admission to the cardiac care unit was reduced by 47% for fast tract patients (median 60 minutes in 1987-8 v 32 minutes in 1990, p less than 0.001) and by 25% for all patients (60 minutes v 45 minutes, p less than 0.001). CONCLUSION--This fast track system requires no additional staff or equipment, and it halves inhospital delay to thrombolytic treatment without affecting the accuracy of diagnosis among patients requiring thrombolysis.

[1]  C. Wilson,et al.  Thrombolytic therapy within one hour of the onset of acute myocardial infarction. , 1991, The Quarterly journal of medicine.

[2]  A. Hughes,et al.  Symptomatic and silent gall stones in the community. , 1991, Gut.

[3]  H. Hod,et al.  Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study. , 1990, Journal of the American College of Cardiology.

[4]  P. Kudenchuk,et al.  Myocardial Infarction Triage and Intervention Project--phase I: patient characteristics and feasibility of prehospital initiation of thrombolytic therapy. , 1990, Journal of the American College of Cardiology.

[5]  J. Manson,et al.  Time to presentation for acute mi in the us physicians' health study , 1990 .

[6]  A. Castaigne,et al.  Prehospital use of APSAC: results of a placebo-controlled study. , 1989, The American journal of cardiology.

[7]  F. Dunn,et al.  Impact of a policy of direct admission to a coronary care unit on use of thrombolytic treatment. , 1989, British heart journal.

[8]  F. Van de Werf,et al.  Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction. , 1988, BMJ.

[9]  A. M. Skene,et al.  TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION Anglo-Scandinavian Study of Early Thrombolysis (ASSET) , 1988, The Lancet.

[10]  T M Hayes,et al.  Associations of alcohol consumption with plasma high density lipoprotein cholesterol and its major subfractions: the Caerphilly and Speedwell Collaborative Heart Disease Studies. , 1988, Journal of epidemiology and community health.

[11]  L. Bossaert,et al.  Prehospital thrombolytic treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex. , 1988, Critical care medicine.

[12]  L. Bolognese,et al.  RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2 , 1988, The Lancet.

[13]  B. Butland,et al.  Dietary determinants of plasma lipids and lipoproteins: the Caerphilly Study. , 1988, European journal of clinical nutrition.

[14]  N. Haites,et al.  Patient and general practitioner delays in acute myocardial infarction , 1988, British medical journal.

[15]  Aims Trial Study Group EFFECT OF INTRAVENOUS APSAC ON MORTALITY AFTER ACUTE MYOCARDIAL INFARCTION: PRELIMINARY REPORT OF A PLACEBO-CONTROLLED CLINICAL TRIAL , 1988, The Lancet.

[16]  B. Chaitman,et al.  The Thrombolysis in Myocardial Infarction (TIMI) phase II pilot study: tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty. , 1987, Journal of the American College of Cardiology.

[17]  B. Sobel,et al.  The temporal pattern of recovery of myocardial perfusion and metabolism delineated by positron emission tomography after coronary thrombolysis. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  M. Criqui,et al.  Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results form the Lipid Research Clinics Follow-up Study. , 1987, American journal of epidemiology.

[19]  W. Willett,et al.  Moderate alcohol consumption and the risk of breast cancer. , 1987, The New England journal of medicine.

[20]  G. Steiner,et al.  Hypertriglyceridemia and carbohydrate intolerance: interrelations and therapeutic implications. , 1986, The American journal of cardiology.

[21]  M. Gotsman,et al.  Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. , 1985, The New England journal of medicine.

[22]  R. Krauss,et al.  The effect of cessation and resumption of moderate alcohol intake on serum high-density-lipoprotein subfractions. A controlled study. , 1984, The New England journal of medicine.

[23]  F. Sheehan,et al.  Effect of interventions in salvaging left ventricular function in acute myocardial infarction: a study of intracoronary streptokinase. , 1983, The American journal of cardiology.

[24]  M. Taskinen,et al.  High density lipoprotein subfractions and postheparin plasma lipases in alcoholic men before and after ethanol withdrawal. , 1982, Metabolism: clinical and experimental.

[25]  B. Lewis,et al.  Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. , 1981, British medical journal.

[26]  M. Brown,et al.  Effect of alterations of the specific activity of the intracellular acetyl CoA pool on apparent rates of hepatic cholesterogenesis. , 1974, Journal of lipid research.

[27]  S. Berger,et al.  Potentiation of the Plasma Insulin Response to Glucose by Prior Administration of Alcohol: An Apparent Islet-Priming Effect , 1969, Diabetes.

[28]  D. Chamberlain,et al.  Reduction in hospital time to thrombolytic therapy by audit of policy guidelines. , 1990, European heart journal.

[29]  A. Pell,et al.  Delays in admission of patients with acute myocardial infarction to coronary care: implications for thrombolysis. , 1990, Health bulletin.

[30]  Potential time saving with pre-hospital intervention in acute myocardial infarction. Report of the European Myocardial Infarction Project (E.M.I.P) Sub-Committee. , 1988, European heart journal.

[31]  P. Emmett,et al.  Glucose and insulin responses to manufactured and whole-food snacks. , 1987, The American journal of clinical nutrition.

[32]  S. Singh,et al.  Effect of ethanol and its metabolites on glucose mediated insulin release from isolated islets of rats. , 1979, Metabolism: clinical and experimental.

[33]  K. Pyörälà,et al.  Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. , 1979, Diabetes care.